ACRYSTA Trademark

Trademark Overview

On Friday, May 24, 2024, a trademark application was filed for ACRYSTA with the United States Patent and Trademark Office. The USPTO has given the ACRYSTA trademark a serial number of 98568282. The federal status of this trademark filing is REGISTERED as of Tuesday, April 7, 2026. This trademark is owned by ESTEVE PHARMACEUTICALS, S.A.. The ACRYSTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain
acrysta

General Information

Serial Number98568282
Word MarkACRYSTA
Filing DateFriday, May 24, 2024
Status700 - REGISTERED
Status DateTuesday, April 7, 2026
Registration Number8200722
Registration DateTuesday, April 7, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBarcelona 08038
ES
Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBarcelona 08038
ES
Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBarcelona 08038
ES

Trademark Events

Event DateEvent Description
Friday, May 24, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 30, 2024ASSIGNED TO EXAMINER
Monday, November 4, 2024NON-FINAL ACTION WRITTEN
Monday, November 4, 2024NON-FINAL ACTION E-MAILED
Monday, November 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 29, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, January 29, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, May 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 12, 2025SUSPENSION LETTER WRITTEN
Monday, May 12, 2025LETTER OF SUSPENSION E-MAILED
Monday, May 12, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 13, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, January 21, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 11, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 17, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 17, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 17, 2026TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, April 7, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, April 7, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, April 10, 2026ASSIGNED TO PETITION STAFF
Sunday, April 12, 2026POST PUBLICATION AMENDMENT – NOT ENTERED

Related Keywords

acrysta pain treatment preparations pharmaceutical